Synergy in natural medicines: implications for drug discovery

Trends in Pharmacological Sciences

Volumn 29, Issue 7, 2008, Pages 331-332

  Li, Xue Juan ^a   Zhang, Hong Yu ^a  

^a SHANDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELASTROL; GLYCYRRHIZIC ACID; INDIRUBIN; NATURAL PRODUCT; TANSHINONE; TETRAARSENIC TETRASULFIDE; TRIPTOLIDE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; CHINESE MEDICINE; DRUG POTENTIATION; DRUG RESEARCH; DRUG STRUCTURE; HUMAN; LETTER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; UNSPECIFIED SIDE EFFECT;

DRUG DESIGN; DRUG RESISTANCE, MULTIPLE; HUMANS; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; PLANTS, MEDICINAL;

EID: 45849091861     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2008.04.002     Document Type: Letter

References (16)

1. Ruffolo R.R. Why has R&D productivity declined in the pharmaceutical industry?. Exp. Opin. Drug Discov. 1 (2006) 99-102
2. Corson T.W., and Crews C.M. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 130 (2007) 769-774
3. Keith C.T., et al. Multicomponent therapeutics for networked systems. Nat. Rev. Drug Discov. 4 (2005) 71-78
4. Stermitz F.R., et al. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1433-1437
5. Li X.-J., and Zhang H.-Y. Western-medicine-validated anti-tumor agents and traditional Chinese medicine. Trends Mol. Med. 14 (2008) 1-2
6. Qiu J. A culture in the balance. Nature 448 (2007) 126-128
7. Huang S.L., et al. Clinical study on the treatment of acute promyelocytic leukemia with Composite Indigo Naturalis tablets. Chin. J. Hematol. 16 (1995) 26-28
8. Wang L., et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 4826-4831
9. Qiu D., and Kao P.N. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D. 4 (2003) 1-18
10. Pinna G.F., et al. Celastrol inhibits pro-inflammatory cytokine secretion in Crohn's disease biopsies. Biochem. Biophys. Res. Commun. 322 (2004) 778-786
11. Zhang W.D., et al. Effect of combination glycyrrhizin and triptolide on TNF-α and L-10 in serum of collagen induced arthritis rats. China J. Chin. Mater. Med. 32 (2007) 414-417
12. Wan F., and Zhong G.S. A medication comparison between Prescriptions for Fifty-two Diseases and Ten Thousands Things. Acta Med. Sin. 5 (1990) 55-58
13. Nie H.M. On features and advantages of composing prescriptions in Treatise on Exogenous Febrile and Miscellaneous Diseases. J. Tradit. Chin. Med. 47 (2006) 806-810
14. 4) in patients with acute promyelocytic leukemia. J. Exp. Hematol. 11 (2003) 464-468
15. Lee K.-H. Research and discovery trends of Chinese medicine in the new century. J. Chin. Med. 15 (2004) 151-160
16. Arase Y., et al. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79 (1997) 1494-1500